Clinical Trial Update: TOMO Versus IMRT in Nasopharyngeal Carcinoma Patients

View source ↗

Summary

A clinical trial update comparing tomotherapy (TOMO) to standard IMRT in nasopharyngeal carcinoma. No results or status details are provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Nasopharyngeal Carcinoma | Status: UNKNOWN